Tandem Diabetes Care, Inc.
TNDM
$22.73
-$0.12-0.53%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -29.98% | 56.86% | 39.18% | 39.19% | 30.58% |
Total Depreciation and Amortization | 3.14% | 5.68% | 6.97% | 9.42% | 16.06% |
Total Amortization of Deferred Charges | -17.31% | -5.22% | -5.97% | 13.49% | 19.89% |
Total Other Non-Cash Items | 76.81% | -40.53% | -44.17% | -55.45% | -46.98% |
Change in Net Operating Assets | -77.23% | 33.38% | 111.78% | 69.69% | -42.82% |
Cash from Operations | 164.91% | 176.16% | 133.51% | -499.53% | -217.13% |
Capital Expenditure | 20.92% | 28.25% | 21.56% | 39.45% | 44.31% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | 100.00% | 100.00% | 100.00% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 120.22% | -140.26% | -137.42% | -139.61% | -130.65% |
Cash from Investing | 85.67% | 72.61% | -35.04% | -7,597.97% | -4,026.13% |
Total Debt Issued | -96.94% | -- | -- | -- | -- |
Total Debt Repaid | 100.00% | -- | -- | -- | -- |
Issuance of Common Stock | -64.94% | -64.94% | -73.96% | -73.96% | -54.48% |
Repurchase of Common Stock | 63.39% | -1,539.31% | -1,539.31% | -3,894.84% | -3,564.95% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 40.13% | -35,153.52% | -35,153.52% | -6,097.78% | -2,226.07% |
Cash from Financing | -154.31% | 103.43% | 14.30% | 29.28% | 42.10% |
Foreign Exchange rate Adjustments | 81.32% | 692.45% | -223.04% | -121.68% | -185.06% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 92.14% | 109.12% | 30.79% | -626.16% | -301.82% |